Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Sona Nanotech Inc > It is over for a while
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1206)
•••
Comment by Moemoney42on Nov 25, 2020 7:06pm
243 Views
Post# 31975398

RE:It is over for a while

RE:It is over for a while
chris579457 wrote:
It is over , no more 16$
 
I guess I could repeat myself here : 
 
1/ they will have to resubmit that application with changes 
2/ it will take some time again to do that 
3/ it costs money to do that, it is not free and every one there will need to be paid too for whatever work they do 
4/ time is running away from some companies in this Covid story because others do have already Rapid Testing product that is authorized and/or approved for sales and distribution like FDA and EUA including contract and sales that has started already 

I'd like to add 
#5/ the company is virtually broke... who's gonna pony up a financing to pursue this further.... and at what price...? Not looking good..!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities